Proton MRI assessment of lung structure and function in people with cystic fibrosis
J. Brooke (Nottingham, United Kingdom), S. Safavi (Nottingham, United Kingdom), A. Prayle (Nottingham, United Kingdom), C. Ng (Nottingham, United Kingdom), J. Paul (Nottingham, United Kingdom), C. Bradley (Nottingham, United Kingdom), A. Cooper (Nottingham, United Kingdom), S. Munidasa (Toronto, Canada), B. Zanette (Toronto, Canada), G. Santyr (Toronto, Canada), H. Barr (Nottingham, United Kingdom), G. Major (Nottingham, United Kingdom), A. Smyth (Nottingham, United Kingdom), P. Gowland (Nottingham, United Kingdom), S. Francis (Nottingham, United Kingdom), I. Hall (Nottingham, United Kingdom)
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Brooke (Nottingham, United Kingdom), S. Safavi (Nottingham, United Kingdom), A. Prayle (Nottingham, United Kingdom), C. Ng (Nottingham, United Kingdom), J. Paul (Nottingham, United Kingdom), C. Bradley (Nottingham, United Kingdom), A. Cooper (Nottingham, United Kingdom), S. Munidasa (Toronto, Canada), B. Zanette (Toronto, Canada), G. Santyr (Toronto, Canada), H. Barr (Nottingham, United Kingdom), G. Major (Nottingham, United Kingdom), A. Smyth (Nottingham, United Kingdom), P. Gowland (Nottingham, United Kingdom), S. Francis (Nottingham, United Kingdom), I. Hall (Nottingham, United Kingdom). Proton MRI assessment of lung structure and function in people with cystic fibrosis. 350
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: